- Innogenetics
Innogenetics is a
Belgium -based international biopharmaceutical company, with headquarters inGhent , Belgium. The company has two divisions: a specialty diagnostics business, and a therapeutics business that develops therapeuticvaccine s.Christiaan De Wilde is the CEO of the company.History
Innogenetics was founded on
18 July 1985 , byErik Tambuyzer ,Hugo Van Heuverswyn andRudi Mariën . In1992 , the company launched the first commercial tests forcystic fibrosis inEurope (INNO-LiPA CFTR) and in1993 the first commercial test forHepatitis C virus (HCV)genotyping worldwide (INNO-LiPA HCV). In1995 , the first commercial Alzheimer’s disease research test for hTau was launched (INNOTEST hTau Ag). In1998 , the company launched the first commercial Alzheimer’s disease research test for β-Amyloid and in2002 the first commercial test forHepatitis B virus (HBV) genotyping (INNO-LiPA HBV Genotyping).The company was one of the first biotech companies to be listed on a European
stock exchange , in1996 it was the first biotech company listed on EASDAQ, nowNASDAQ Europe. Innogenetics currently has its shares traded onEuronext Brussels . On1 October 2007 , the therapeutics division was separated into a new company "GENimmune NV" for the development of immune therapeutics.ee also
*
EuropaBio
*FlandersBio ource
* [http://www.innogenetics.com/site/annualreport.html Annual report]
* Jannes G, De Vos D., A review of current and future molecular diagnostic tests for use in the microbiology laboratory, Methods Mol Biol. 2006;345:1-21.
* Tortoli E, Marcelli F.,Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility, Eur J Clin Microbiol Infect Dis. 2007, Jan;26(1):51-5.External links
* [http://www.innogenetics.com/ Innogenetics]
Wikimedia Foundation. 2010.